Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace's comprehensive suite of technologies for its growing customer base

Apr. 7, 2026 at 2:21pm

A ghostly, translucent X-ray photograph revealing the intricate internal structure of a compression screw, its threads and beveled head glowing against a dark background, conceptually illustrating the advanced design of Treace's new surgical implant.Treace's new SuperBite™ compression screws promise enhanced fixation and streamlined insertion for a wide range of foot and ankle procedures.NYC Today

Treace Medical Concepts, Inc. announced the successful completion of the first cases utilizing its new SuperBite™ Compression Screw System. The SuperBite™ screws are engineered to deliver advanced compression through a variable thread pitch and optimized headless design, with self-drilling and countersinking features enabling rapid screw insertion. The screw implants also incorporate a beveled head design with smoothed edges, making them ideal for both minimally invasive and traditional open surgical approaches. The SuperBite™ system offers comprehensive screw diameters ranging from 2.5mm to 7.0mm to address a broad range of foot & ankle surgical applications across the forefoot, midfoot, and hindfoot.

Why it matters

The launch of SuperBite™ represents an important milestone in the expansion of Treace's market-leading bunion & midfoot technology portfolio. SuperBite™ allows Treace's direct sales team to more fully service its 3,300+ surgeon customers' technology needs, not only in the procedures they perform with Treace today, but also a significant volume of incremental procedures throughout the foot and ankle where compression screws are utilized. Treace believes SuperBite™ screws will expand its addressable market, accelerate its case volumes, and grow its customer share of wallet, all while further advancing its position as a 1-stop-shop for its customers.

The details

The first cases with the new SuperBite™ screws were performed by Anne Holly Johnson, MD, of Hospital for Special Surgery (New York, New York) and a member of Treace's Surgeon Advisory Board. Dr. Johnson commented, "My first cases with the SuperBite™ screws were very successful. I was impressed with the streamlined insertion and great compression. Compression screws are the most common fixation used in foot and ankle surgery, and I plan to use the SuperBite™ screws in many different fusion and osteotomy applications."

  • Full commercialization of the SuperBite™ Compression Screw System is anticipated in the third quarter of 2026.

The players

Treace Medical Concepts, Inc.

A medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities.

Anne Holly Johnson, MD

A surgeon at Hospital for Special Surgery (New York, New York) and a member of Treace's Surgeon Advisory Board.

Got photos? Submit your photos here. ›

What they’re saying

“My first cases with the SuperBite™ screws were very successful. I was impressed with the streamlined insertion and great compression. Compression screws are the most common fixation used in foot and ankle surgery, and I plan to use the SuperBite™ screws in many different fusion and osteotomy applications.”

— Anne Holly Johnson, MD, Surgeon, Hospital for Special Surgery

What’s next

Along with its other expected 2026 product launch, the SpeedXM™ Midfoot Fusion System, the two products are expected to increase Treace's total addressable market by an estimated $300 million.

The takeaway

Treace's new SuperBite™ Compression Screw System represents a significant expansion of its portfolio of innovative technologies for foot and ankle surgeons, positioning the company as a comprehensive 'one-stop-shop' for a wide range of procedures beyond its core bunion and midfoot offerings.